mazindol has been researched along with Dyspepsia in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Dyspepsia: Impaired digestion, especially after eating.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baird, IM | 1 |
| Howard, AN | 1 |
1 trial available for mazindol and Dyspepsia
| Article | Year |
|---|---|
A double-blind trial of mazindol using a very low calorie formula diet.
Topics: Adolescent; Adult; Clinical Trials as Topic; Diet, Reducing; Dizziness; Double-Blind Method; Drug Ev | 1977 |